NOV 24, 2015 12:08 PM PST

Brain Inflammation Linked to Persistant Depression Symptoms

WRITTEN BY: Kara Marker
A large number of people diagnosed with depression experience an inability to feel pleasure, and antidepressants don't seem to be helping. A new study from Emory Health Sciences has shown that inflammation in the brain is causing the disconnect, and anti-inflammatory drugs could reverse the effect.

"Anhedonia," also know as the loss in interest of previously pleasing activities like talking with friends, being outside or listening to music, is a common symptom of people with major depressive disorder (Psychology Today). Newly linked to inflammation, prior to this discovery doctors were unsure why antidepressants did not solve this problem associated with depression. 

In a study published this month in Molecular Psychiatry, scientists from Emory looked at brain images of 48 patients diagnosed with depression to investigate the potential of this "inflammatory depression." They analyzed the levels of c-reactive protein (CRP), an inflammatory marker produced by the liver in response to inflammation in the body (MedlinePlus). They collected brain images of their participants while they were not on any antidepressants or other drugs and compared the images to their CRP levels.
C-reactive protein

A clear connection was made between patients experiencing and reporting anhedonia and high levels of CRP circulating in their blood. In addition, brain images from these patients showed "low functional connectivity" between two regions of the brain related to motivation and reward. Patients with low levels of CRP did not report experiencing anhedonia and had normal connectivity between these brain regions.

"We were interested in these regions of the brain because of their known importance for response to reward," said lead author Jennifer Felger, PhD, assistant professor of psychiatry and behavioral sciences at Emory University School of Medicine and Winship Cancer Institute.

Scientists were also prompted to make this connection since decreased activity of the same two brain regions was seen in hepatitis C patients receiving "immuno-stimulatory" treatments that boosted inflammation. Scientists have begun using anti-inflammatory treatments for anhedonia patients and seen improvement. No change was seen in patients without anhedonia when given the same treatment. 

The next step, being pursued by the same group from Emory, is to test the effectiveness of L-DOPA therapy on anhedonia patients. L-DOPA therapy is currently used to treat Parkinson's disease by acting as a neurotransmitter and stimulating brain activity. 

Watch the following video to learn more about L-DOPA and how it works.

Source: Emory Woodruff Health Sciences Center
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 23, 2018
Immunology
MAY 23, 2018
Isolating The Source of Interleukin-25 In Common Respiratory Disorders
The latest discovery from the Perelman School of Medicine at the University of Pennsylvania examined the mechanisms behind how the immune system responds t...
JUL 10, 2018
Health & Medicine
JUL 10, 2018
Towards a Universal Flu Vaccine
Each year, depending on the weather and other factors, flu season shows up and sometimes it’s really bad and other times it’s not as widespread...
JUL 28, 2018
Immunology
JUL 28, 2018
IgM Antibody Protects against HIV-1 Infection
The antibody IgM is shown to be provide protection against HIV infection in rhesus monkeys up to 82 days past exposure to HIV....
AUG 22, 2018
Immunology
AUG 22, 2018
Immune Response Runs on the Body Clock
Immune cell functions such as inflammation are dictated by your bodies circadian rhythm, responding daily to external stimuli on a 24 hour schedule....
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
AUG 29, 2018
Immunology
AUG 29, 2018
Immune System Prioritizes Response when Faced with Multiple Threats
The Innate Immune response prioritizes lung infection and cell repair over other threats in both infants and adults....
Loading Comments...